VTAK
Income statement / Annual
Last year (2023), Catheter Precision, Inc.'s total revenue was $442,000.00,
an increase of 3,057.14% from the previous year.
In 2023, Catheter Precision, Inc.'s net income was -$70.57 M.
See Catheter Precision, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$442,000.00
|
$14,000.00
|
$22,000.00
|
$4.41 M
|
$7.20 M
|
$6.26 M
|
$5.87 M
|
$5.98 M
|
| Cost of Revenue |
$30,000.00 |
$161,000.00 |
$1.56 M |
$5.48 M |
$8.85 M |
$4.21 M |
$4.17 M |
$3.14 M |
| Gross Profit |
$412,000.00 |
-$147,000.00 |
-$1.54 M |
-$1.08 M |
-$1.65 M |
$2.05 M |
$1.71 M |
$2.84 M |
| Gross Profit Ratio |
0.93 |
-10.5 |
-69.91 |
-0.24 |
-0.23 |
0.33 |
0.29 |
0.47 |
| Research and Development
Expenses |
$475,000.00
|
$6.39 M
|
$12.25 M
|
$9.01 M
|
$4.53 M
|
$2.78 M
|
$4.52 M
|
$1.72 M
|
| General & Administrative
Expenses |
$0.00
|
$2.23 M
|
$0.00
|
$25.97 M
|
$51.55 M
|
$30.44 M
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$1.25 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$17.12 M
|
$16.25 M
|
$15.48 M
|
$25.97 M
|
$51.55 M
|
$30.44 M
|
$14.95 M
|
$5.32 M
|
| Other Expenses |
$60.93 M |
$99,000.00 |
$2.01 M |
$21,000.00 |
$788,000.00 |
$338,000.00 |
$14.95 M |
$5.32 M |
| Operating Expenses |
$15.52 M |
$22.64 M |
$27.73 M |
$34.98 M |
$56.08 M |
$33.21 M |
$19.47 M |
$7.04 M |
| Cost And Expenses |
$78.56 M |
$22.80 M |
$29.29 M |
$40.46 M |
$64.93 M |
$37.42 M |
$23.63 M |
$10.17 M |
| Interest Income |
$347,000.00 |
$0.00 |
$0.00 |
$129,000.00 |
$1.04 M |
$352,000.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$3.08 M |
$0.00 |
$108,000.00 |
$250,000.00 |
$14,000.00 |
$4,000.00 |
$3,000.00 |
| Depreciation &
Amortization |
$2.08 M
|
$421,000.00
|
$1.40 M
|
$2.00 M
|
$1.75 M
|
$624,000.00
|
$218,000.00
|
$95,000.00
|
| EBITDA |
-$15.11 M
|
-$22.37 M
|
-$27.70 M
|
-$33.30 M
|
-$54.94 M
|
-$30.18 M
|
-$17.54 M
|
-$4.10 M
|
| EBITDA Ratio |
-34.19 |
-1299.71 |
-1330.27 |
-8.19 |
-8.02 |
-4.98 |
-2.99 |
-0.69 |
| Operating Income Ratio
|
-176.74
|
-1925.79
|
-1330.27
|
-8.19
|
-8.02
|
-4.98
|
-3.03
|
-0.7
|
| Total Other
Income/Expenses Net |
$7.55 M
|
-$4.07 M
|
$2.01 M
|
$88,000.00
|
$788,000.00
|
$338,000.00
|
-$4,000.00
|
-$3,000.00
|
| Income Before Tax |
-$70.57 M |
-$26.86 M |
-$27.26 M |
-$36.04 M |
-$56.94 M |
-$30.82 M |
-$17.76 M |
-$4.20 M |
| Income Before Tax Ratio
|
-159.67
|
-1918.71
|
-1238.95
|
-8.18
|
-7.91
|
-4.93
|
-3.03
|
-0.7
|
| Income Tax Expense |
$0.00 |
$3,000.00 |
$4,000.00 |
$7,000.00 |
$15,000.00 |
$10,000.00 |
$1,000.00 |
$1,000.00 |
| Net Income |
-$70.57 M |
-$26.87 M |
-$25.07 M |
-$36.05 M |
-$56.96 M |
-$30.83 M |
-$17.77 M |
-$4.20 M |
| Net Income Ratio |
-159.67 |
-1918.93 |
-1139.55 |
-8.18 |
-7.91 |
-4.93 |
-3.03 |
-0.7 |
| EPS |
-12.99 |
-25.98 |
-248.22 |
-1060.77 |
-5416.22 |
-4175.51 |
-1834.66 |
-433.96 |
| EPS Diluted |
-12.99 |
-25.98 |
-248.22 |
-1060.77 |
-5416.22 |
-4175.51 |
-1834.66 |
-433.96 |
| Weighted Average Shares
Out |
$5.50 M
|
$1.03 M
|
$101,000.00
|
$33,980.00
|
$10,516.00
|
$7,384.00
|
$9,683.00
|
$9,683.00
|
| Weighted Average Shares
Out Diluted |
$5.50 M
|
$1.03 M
|
$101,000.00
|
$33,980.00
|
$10,516.00
|
$7,384.00
|
$9,683.00
|
$9,683.00
|
| Link |
|
|
|
|
|
|
|
|
